Medmain Inc.

【We are on the stage in Silicon Valley; that Japan Innovation Campus, by the Ministry of Economy, Trade, and Industry of Japan, for the Japanese startups】 Medmain Inc., a provider of the digital pathology support solution “PidPort,” is pleased to announce that we have been selected as a coworking member of “Japan Innovation Campus,” a new base for Japanese startups established in Silicon Valley, USA by the Ministry of Economy, Trade, and Industry (Head Office: Tokyo, Japan; hereinafter “METI,”) which is one of the government agencies of Japan, responsible for national policy formulation and implementation related to Japan’s economy, trade, and industry such as renewable energy, robotics industry, environmental policies and medical devices. Through our activities at this base, we will accelerate our business expansion in the United States. ■About Japan Innovation Campus METI has established “Japan Innovation Campus” in Silicon Valley (City of Palo Alto), the U.S., one of the most developed startup ecosystems in the world, as a joint effort with the local public, industrial, and academic sectors to support Japanese startups aiming to expand business overseas. METI will work together with local private companies, including accelerators and venture capital firms, world top-class universities and academic institutions, including Stanford University and the University of California, Berkeley, and administrative organizations, including the Japan External Trade Organization (JETRO), to support Japanese startups in fund raising and business development in the U.S., and also support Japanese companies in collaborating with startups and venture capital firms in the U.S., and other activities. For more details: https://lnkd.in/ge99sPfa #Pathology #DeepLearning #AI #Medmain

【Promoting the Social Implementation of Pathological AI Developed by JP-AID and the University of Tokyo】 Dr. Hiroyuki Abe, Senior lecturer at the University of Tokyo (Head Office: Tokyo, Japan), gave an announcement on the achievements and future prospects of the Japan Pathology AI Diagnostics Project (hereinafter “JP-AID”), at the 69th Autumn Annual Meeting of the Japanese Society of Pathology. The JP-AID is a project initiated by the Japanese Society of Pathology (Head Office: Tokyo, Japan) with support from Japan Agency for Medical Research and Development (Head Office: Tokyo, Japan; hereinafter “AMED”). As a JP-AID project, the University of Tokyo and the National Institute of Informatics (Head Office: Tokyo, Japan; hereinafter “NII”) have jointly developed AI to assist in the pathological diagnosis of gastric biopsies. It was announced at the meeting that this AI-powered system for gastric biopsies will be developed as a software as medical device (SaMD) to support pathological diagnosis with the aim of obtaining regulatory approval and implementing it in society, in the “Medical Innovation Promotion Project (Development and Commercialization Project)” selected by AMED. Medmain Inc. will help reduce the workload of busy pathologists with this AI to support pathological diagnosis. It is also expected to promote the elimination of the cancer-care disparity by incorporating it into the telepathology diagnosis for doctors. #Pathology #DeepLearning #AI #Medmain いいね！ コメントする シェア

【We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Vietnam!】 We participated in the “Viet Nam – Japan Medical ICT and Aging Workshop” held in Hà Nội, Vietnam on October 31, 2023, hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan. Over 100 medical professionals and business people, mainly from the Hanoi Medical University Hospital, attended the event. We gave a demonstration of our “PidPort”, an AI-powered cloud system for digital pathology support and received significant interest from the attendees. It was a very meaningful opportunity for us. We will present our achievement of this workshop at the “Medical ICT and Aging Business Seminar Insight Sharing and Future Collaboration between Viet Nam and Japan” on Monday, December 11, hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan. Date and Time: Monday, December 11, 2023 @3:30 pm～5:30 pm Style: Hybrid Venue: Nihonbashi area, Tokyo Fee: Free of Charge #Pathology #DeepLearning #AI #Medmain

【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】 We had a booth at “SWITCH 2023 (Singapore Week of Innovation & Technology),” Singapore’s largest startup events, held at the Sands Expo and Convention Centre (Marina Bay Sands) in Singapore from Tuesday, October 31 to Thursday, November 2, 2023, and introduced “PidPort,” an AI-powered cloud system for digital pathology support. SWITCH is an event where leaders of the global and Asian innovation ecosystem, entrepreneurs, investors, and others gather to discuss and exchange ideas. In addition to the booth exhibition, there was a pitch contest, a matching program with local startups, and a networking event, and many people from all over the world attended the event for the three days. We were honored to have Mr. Heng Swee Keat, Deputy Prime Minister and Coordinating Minister for Economic Policies, visit our booth and had a chance to introduce our efforts. We would like to express our sincere gratitude to Fukuoka City and JETRO Fukuoka for their cooperation and support, to everyone who supported us at the venue, and all the attendees who visited our booth. Thank you very much for this valuable opportunity. #Pathology #DeepLearning #AI #Medmain

【Announcement of Participation in the "Viet Nam - Japan Medical ICT and Aging Workshop" hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】 Medmain Inc., a provider of the digital pathology support solution "PidPort," is pleased to announce that it will be participating in the "Viet Nam - Japan Medical ICT and Aging Workshop" to be held in Hà Nội, Vietnam on October 31, 2023, hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan. We will have a demonstration of our "PidPort", an AI-powered cloud system for digital pathology support. For more details: https://lnkd.in/gRHcJh8A #Pathology #DeepLearning #AI #Medmain

Medmain Inc. will introduce PidPort, the AI-powered cloud system designed to support digital pathology, at the upcoming "Philadelphia Alliance for Capital and Technology Conference", the largest annual startup conference in Philadelphia, which will be held in November 2023.

【Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech】 Medmain Inc., a Japanese MedTech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has been selected for the “U.S. Market Gateway Accelerator for BioSciences and MedTech”, an acceleration program sponsored by WorldUpstart, LLC. We will take advantage of this opportunity to move forward with our business development in the U.S. Fore more details: https://lnkd.in/gWA2MVrQ #Pathology #DeepLearning #AI #Medmain